633 related articles for article (PubMed ID: 29875626)
1. Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.
Franco-Iborra S; Vila M; Perier C
Front Neurosci; 2018; 12():342. PubMed ID: 29875626
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
5. Unravelling mitochondrial pathways to Parkinson's disease.
Celardo I; Martins LM; Gandhi S
Br J Pharmacol; 2014 Apr; 171(8):1943-57. PubMed ID: 24117181
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction in neurodegenerative disorders.
Klemmensen MM; Borrowman SH; Pearce C; Pyles B; Chandra B
Neurotherapeutics; 2024 Jan; 21(1):e00292. PubMed ID: 38241161
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.
Chaturvedi RK; Beal MF
Mol Cell Neurosci; 2013 Jul; 55():101-14. PubMed ID: 23220289
[TBL] [Abstract][Full Text] [Related]
9. Neurodegeneration as a consequence of failed mitochondrial maintenance.
Karbowski M; Neutzner A
Acta Neuropathol; 2012 Feb; 123(2):157-71. PubMed ID: 22143516
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Biology and Neurological Diseases.
Arun S; Liu L; Donmez G
Curr Neuropharmacol; 2016; 14(2):143-54. PubMed ID: 26903445
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dysfunction in Huntington's Disease: Pathogenesis and Therapeutic Opportunities.
Sharma A; Behl T; Sharma L; Aelya L; Bungau S
Curr Drug Targets; 2021; 22(14):1637-1667. PubMed ID: 33655829
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria, oxidative stress and neurodegeneration.
Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.
Gao J; Wang L; Liu J; Xie F; Su B; Wang X
Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28379197
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?
Hu D; Liu Z; Qi X
Front Neurosci; 2021; 15():746873. PubMed ID: 34867159
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.
Schapira AH
Biochim Biophys Acta; 1999 Feb; 1410(2):159-70. PubMed ID: 10076024
[TBL] [Abstract][Full Text] [Related]
16. The multi-faceted role of mitochondria in the pathology of Parkinson's disease.
Trinh D; Israwi AR; Arathoon LR; Gleave JA; Nash JE
J Neurochem; 2021 Mar; 156(6):715-752. PubMed ID: 33616931
[TBL] [Abstract][Full Text] [Related]
17. Autophagy and Mitochondria: Targets in Neurodegenerative Disorders.
Kumar A; Dhawan A; Kadam A; Shinde A
CNS Neurol Disord Drug Targets; 2018; 17(9):696-705. PubMed ID: 30113005
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease.
Pantiya P; Thonusin C; Chattipakorn N; Chattipakorn SC
Mitochondrion; 2020 Nov; 55():14-47. PubMed ID: 32828969
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases.
Bartman S; Coppotelli G; Ross JM
Curr Issues Mol Biol; 2024 Mar; 46(3):1987-2026. PubMed ID: 38534746
[TBL] [Abstract][Full Text] [Related]
20. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
Singh A; Kukreti R; Saso L; Kukreti S
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
